Why is #drugrepositioning important to bridge the innovation deficit?
Drug repositioning takes several forms and repositioning FDA approved drugs is one manner in which to adopt drug repurposing practice into your..
Posts in the Orphan Drugs category
#Drugrepositioning not associated with lengthy and costly drug development
Is drug repositioning a solution or THE solution? Patent cliffs are turning up the scrutiny on current drug development timelines and rising..
What happens when the supply of drugs are scarce? – HHS report
What could be more shocking than a medical diagnosis? A critical shortage of drug. Generic drugmakers and FDA have declared a joint effort to..
Developing countries need Orphan Drugs
The need for orphan drugs has been on the rise in recent years, and is especially so in developing countries. In many cases, nobody is investing..
A niche market for the biopharma industry – orphan drugs
On the basis that 6-10% of the world’s population will suffer from a rare disease at one point in life, the markets of Asia-Pacific should..
Orphan Drugs in Asia
Source: Pharma Focus Asia In recent years, Asia has emerged as the newest frontier in the development of treatments for diseases classified..
